Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

Pan-Asia Catalysts/Events

Quiddity Advisors

Event-Driven

PT Barito Renewables Energy Tbk operates as a holding company. The Company, through its subsidiaries, focuses on long term strategy to provide cleaner and lower emission energy. Barito Renewables Energy develops geothermal energy plants in Indonesia.

<ul>
<li>
<a href="https://www.smartkarma.com/entities/barito-pacific-tbk-pt" target="_blank" data-smartkarma-citation="entities:8851:1" rel="noopener">Barito Pacific (BRPT IJ)</a>'s 64.7% stake in <a href="https://www.smartkarma.com/entities/pt-barito-renewables-energy-tbk" target="_blank" data-smartkarma-citation="entities:40150:1" rel="noopener">Barito Renewables Energy (BREN IJ)</a> (now Indonesia’s largest company by market cap), is worth 8x its market cap. That's unsustainable.</li>
<li>Preceding my comments on the Barito complex are the current setup/unwind tables for Asia-Pacific Holdcos.</li>
<li>These relationships trade with a minimum liquidity of US$1mn, and a % market capitalisation &gt;20%.</li>
</ul>



Barito Pacific (BRPT IJ)'s 64.7% stake in Barito Renewables Energy (BREN IJ) (now Indonesia’s largest company by market cap), is worth 8x its market cap. That's unsustainable.
Preceding my comments on the Barito complex are the current setup/unwind tables for Asia-Pacific Holdcos.
These relationships trade with a minimum liquidity of US$1mn, and a % market capitalisation &gt;20%.


StubWorld: Barito Renewables (BREN IJ) - This Too Shall Pop

Korea / Special Sits, Pairs, Index Rebalancing, Clepsydra Capital

Sanghyun Park

Korea / Special Sits, Pairs, Index Rebalancing

Clepsydra Capital

Investigate special situations, pairs, and index rebalancing trades in Korea.

SK Bioscience Co.,Ltd. operates biopharmaceutical businesses. The Company produces vaccines, sky cellflu prefilled syringes, sky cellflu quadrivalent prefilled syringes, varicella drugs, and other related products. SK Bioscience markets its products throughout South Korea.

<ul>
<li>The declining appeal of the separator business prompts SK to seek buyers for SKIET through block deals amid financial pressures. The first deal is anticipated despite recent stock price drops.</li>
<li>SK Ecoplant looks to sell its 37.6% stake in SK Oceanplant. Negotiations stall over the former major shareholder's 20% stake, prompting consideration of a block deal.</li>
<li>SK Bioscience, under SK Discovery, faces possible sale amid SK's bio company reshuffle. SK Chemicals may bring SK Biopharm under its wing to help SK Inc focus on semiconductors/batteries.</li>
</ul>


The declining appeal of the separator business prompts SK to seek buyers for SKIET through block deals amid financial pressures. The first deal is anticipated despite recent stock price drops.
SK Ecoplant looks to sell its 37.6% stake in SK Oceanplant. Negotiations stall over the former major shareholder's 20% stake, prompting consideration of a block deal.
SK Bioscience, under SK Discovery, faces possible sale amid SK's bio company reshuffle. SK Chemicals may bring SK Biopharm under its wing to help SK Inc focus on semiconductors/batteries.


Block Deal Prospects Arising from SK Group's Corporate Reshuffle

Head of Research, IPOs & Placements, Aequitas Research

Sumeet Singh

Head of Research, IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

Emcure Pharmaceuticals / Equity Capital Markets

Emcure Pharmaceuticals Limited operates as a pharmaceutical company. The Company manufactures tablets, soft-gel and hard-gel capsules, and injectables, as well as vitamins, minerals, and nutrients 
products. Emcure Pharmaceuticals serves customers worldwide.

<ul>
<li>
<a href="https://www.smartkarma.com/entities/emcure-pharmaceuticals-ltd" target="_blank" data-smartkarma-citation="entities:35585:1" rel="noopener">Emcure Pharmaceuticals</a> is looking to raise around US$240m in its upcoming India IPO.</li>
<li>Emcure Pharmaceuticals (EP) is an Indian Pharmaceutical company engaged in the developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.</li>
<li>We have looked at the company’s past performance, in our earlier note. In this note, we talk about the RHP updates and take a quick look at valuations.</li>
</ul>



Emcure Pharmaceuticals is looking to raise around US$240m in its upcoming India IPO.
Emcure Pharmaceuticals (EP) is an Indian Pharmaceutical company engaged in the developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
We have looked at the company’s past performance, in our earlier note. In this note, we talk about the RHP updates and take a quick look at valuations.


Emcure Pharmaceuticals Pre-IPO - Refiling Updates and Valuations

Research from Water Tower Research, Water Tower Research

Water Tower Research

Research from Water Tower Research

Water Tower Research is a leading equity research firm that provides research on micro, small and mid cap companies.

Water Tower Research was founded by Wall Street veterans after witnessing a fundamental shift in the investment research industry with the result being a declining knowledge base among investors, a lack of awareness and a shrinking pool of fundamental research being conducted on companies across the small-cap and micro-cap spectrum. The same issues are now increasingly occurring in the mid-cap space. This sea change within the investment community is impacting not only the companies themselves but also current shareholders and potential investors. With significantly less active sell-side sponsorship by Wall Street, a substantial information gap has developed between companies and various constituents in the financial community. The net result is fewer channels for insight and information to flow between companies and investors.

Equity Research Firm

Equity Bottom-Up

Pioneer Power Solutions  / Equity Bottom-Up

Pioneer Power Solutions, Inc. manufactures liquid-filled electricity distribution and specialty transformers.  The Company markets its products to electrical utilities, and industrial and commercial construction companies.

<ul><li>The WTR Sustainable Index was down 0.7% W/W versus the S&amp;P 500 Index (down 0.1%), the Russell 2000 Index (up 1.3%), and the Nasdaq Index (down 0.1%).</li><li>Energy Technology (14.2% of the index) was down by 2.7%, while Industrial Climate and Ag Technology (60.5% of the index) was down 0.4%, ClimateTech Mining was down 6.2%, and Advanced Transportation Solutions (19.7% of index) was down 0.2%.</li><li>Top 10 Performers: HLGN, OPTT, EOSE, ARVL, LTBR, NVVE, EGT, ENVX, FFIE, LICY</li></ul>

The WTR Sustainable Index was down 0.7% W/W versus the S&amp;P 500 Index (down 0.1%), the Russell 2000 Index (up 1.3%), and the Nasdaq Index (down 0.1%).Energy Technology (14.2% of the index) was down by 2.7%, while Industrial Climate and Ag Technology (60.5% of the index) was down 0.4%, ClimateTech Mining was down 6.2%, and Advanced Transportation Solutions (19.7% of index) was down 0.2%.Top 10 Performers: HLGN, OPTT, EOSE, ARVL, LTBR, NVVE, EGT, ENVX, FFIE, LICY

Sustainable Investing Surveyor - Focus on Pioneer Power Solutions, Inc. (PPSI) July 2, 2024

External broker reports(aggregated public sources), HDFC Securities

HDFC Securities

External broker reports(aggregated public sources)

HDFC securities is the best online trading platform for stocks, IPOs, mutual fund in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Bharat Petroleum Corporation Limited explores for and refines crude oil. The Company manufactures petroleum, petroleum products, lubricants, liquefied petroleum gas, aromatics like benzene and toluene, and other related products. Bharat has retail outlets throughout the country.

<ul><li>The Bharat Petroleum Corporation (BPCL) stock rallied ~33% and outperformed the Sensex by ~22% over the last 6M</li><li>However, we believe the current market price is still factoring in very optimistic earnings growth on the back of a very strong FY24</li><li>With crude oil prices rising by ~5% from average prices seen in Q4FY24 and rising ~12% to over USD 86/bbl over the last month, we expect this to adversely impact BPCL’s marketing segment profitability, going ahead</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

The Bharat Petroleum Corporation (BPCL) stock rallied ~33% and outperformed the Sensex by ~22% over the last 6MHowever, we believe the current market price is still factoring in very optimistic earnings growth on the back of a very strong FY24With crude oil prices rising by ~5% from average prices seen in Q4FY24 and rising ~12% to over USD 86/bbl over the last month, we expect this to adversely impact BPCL’s marketing segment profitability, going aheadContent is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

BPCL: Demanding Valuation. Maintain REDUCE

Sell / Short Ideas
Outperform on the downside

StubWorld: Barito Renewables (BREN IJ) - This Too Shall Pop

I don't know what is going on. I do know BREN's share price will decline. All stocks - parent and subs - are uninvestable in my view.

David Blennerhassett

Block Deal Prospects Arising from SK Group's Corporate Reshuffle

SK Group seems to have chosen a block deal of SK Innovation's stake in SKIET as the first step to improve SK On's financial structure. SK...

Sanghyun Park

Emcure Pharmaceuticals Pre-IPO - Refiling Updates and Valuations

Emcure Pharmaceuticals is looking to raise around US$240m in its upcoming India IPO. In this note, we talk about valuations.

Sumeet Singh

Sustainable Investing Surveyor - Focus on Pioneer Power Solutions, Inc. (PPSI) July 2, 2024

The WTR Sustainable Index was down 0.7% W/W versus the S&P 500 Index (down 0.1%), the Russell 2000 Index (up 1.3%), and the Nasdaq Index (down 0.1%).

Water Tower Research

BPCL: Demanding Valuation. Maintain REDUCE

With crude oil prices rising by ~5% from average prices seen in Q4FY24 and rising ~12% to over USD 86/bbl over the last month, we expect this to...

HDFC Securities